Jo Sunmi, Shim Hye Kyung
Department of Radiation Oncology, Inje University Haeundae Paik Hospital, Busan, Korea.
Department of Nuclear Medicine, Inje University Haeundae Paik Hospital, Busan, Korea.
Radiat Oncol J. 2013 Dec;31(4):267-72. doi: 10.3857/roj.2013.31.4.267. Epub 2013 Dec 31.
Although significant advances in the treatment of intrahepatic lesions, it is reported that the prognosis for patients with hepatocellular carcinoma (HCC) who have extrahepatic metastasis remains poor. We report a patient with lung, liver, brain, bone and subcutaneous metastasis from HCC who has survived more than 7 years maintaining relatively good performance status as a result of repeated therapies. A 55-year-old male patient with HCC underwent right lobectomy of the liver and cholecystectomy in September 2006. He received wedge resection for lung metastasis twice (July 2009, January 2011) and Gamma Knife stereotactic radiosurgery for brain metastasis (April 2011). Over the last 3 years, he has developed metastasis in subcutaneous tissues, muscle, and bone with pain. He has undergone 7 courses of radiotherapies for subcutaneous tissues, muscle, and bone metastasis and been prescribed sorafenib and he is still capable of all self-care.
尽管肝内病变的治疗取得了重大进展,但据报道,发生肝外转移的肝细胞癌(HCC)患者的预后仍然很差。我们报告了一名HCC发生肺、肝、脑、骨和皮下转移的患者,由于反复治疗,该患者存活了7年多,保持了相对良好的身体状况。一名55岁的男性HCC患者于2006年9月接受了肝右叶切除术和胆囊切除术。他两次接受肺转移楔形切除术(2009年7月、2011年1月),并接受了脑转移伽玛刀立体定向放射治疗(2011年4月)。在过去3年里,他出现了皮下组织、肌肉和骨转移并伴有疼痛。他接受了7个疗程的皮下组织、肌肉和骨转移放射治疗,并服用了索拉非尼,目前仍能自理。